Dose-per-fraction escalation for localized prostate cancer - A multi-institutional phase I/II trial

被引:11
|
作者
Ritter, M. A.
Forman, J. D.
Petereit, D. G.
Kupelian, P. A.
Wang, D.
Walker, W.
Fowler, J. F.
Chappell, R. J.
TAme, W. A.
机构
[1] Univ Wisconsin, Madison, WI USA
[2] Wayne State Univ, Detroit, MI USA
[3] John T Vucurevich Canc Ctr Inst, Rapid City, SD USA
[4] M D Anderson Canc Ctr, Orlando, FL USA
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
关键词
D O I
10.1016/j.ijrobp.2006.07.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
19
引用
收藏
页码:S11 / S11
页数:1
相关论文
共 50 条
  • [31] A multi-institutional cohort of active surveillance for low-risk localized prostate cancer
    Eggener, Scott E.
    Mueller, Alexander
    Berglund, Ryan K.
    Abouassaly, Robert
    Zappavigna, Chris
    Soloway, Cindy T.
    Soloway, Mark S.
    Jones, J. Stephen
    Klein, Eric A.
    Goldenberg, Larry
    Scardino, Peter T.
    Eastham, James A.
    Guillonneau, Bertrand D.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 64 - 64
  • [32] Phase I dose-escalation trial of tremelimumab in combination with bicalutamide in patients with recurrent prostate cancer
    Lang, J. M.
    Staab, M. J.
    Liu, G.
    Wilding, G.
    McNeel, D. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [33] Exercise prescription dose for castrate-resistant prostate cancer patients: a phase I prescription dose escalation trial
    Bultijnck, Renee
    Deforche, Benedicte
    Borrey, Noemi
    Van Bauwel, Joergen
    Lievens, Maarten
    Rammant, Elke
    Fonteyne, Valerie
    Decaestecker, Karel
    Steyaert, Adelheid
    Lumen, Nicolaas
    Ost, Piet
    WORLD JOURNAL OF UROLOGY, 2021, 39 (02) : 357 - 364
  • [34] Exercise prescription dose for castrate-resistant prostate cancer patients: a phase I prescription dose escalation trial
    Renée Bultijnck
    Benedicte Deforche
    Noëmi Borrey
    Jörgen Van Bauwel
    Maarten Lievens
    Elke Rammant
    Valérie Fonteyne
    Karel Decaestecker
    Adelheid Steyaert
    Nicolaas Lumen
    Piet Ost
    World Journal of Urology, 2021, 39 : 357 - 364
  • [35] Multi-institutional registry for prostate cancer radiosurgery: An observational clinical trial.
    Freeman, Debra
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [36] Multi-Institutional registry for prostate cancer radiosurgery: a prospective observational clinical trial
    Freeman, Debra
    Dickerson, Gregg
    Perman, Mark
    FRONTIERS IN ONCOLOGY, 2015, 4
  • [37] Intravaginal high-dose-rate brachytherapy for Stage I endometrial cancer: A randomized study of two dose-per-fraction levels
    Sorbe, B
    Straumits, A
    Karlsson, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (05): : 1385 - 1389
  • [38] Phase I dose escalation trial using single fraction Stereotactic PBI for early stage breast cancer
    Rahimi, A.
    Kim, N.
    Spangler, A.
    Leitch, M.
    Alluri, P.
    Gu, X.
    Ahn, C.
    Goudreau, S.
    Seiler, S.
    Farr, D.
    Wooldridge, R.
    Haley, B.
    Bahrami, S.
    Chen, D.
    Rao, R.
    Timmerman, R.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S706 - S706
  • [39] Phase I Dose Escalation Trial Using 3-Fraction SBRT for Locally Advanced Pancreatic Cancer
    Reyngold, M.
    Karam, S. D.
    Hajj, C.
    Wu, A. J.
    Romesser, P. B.
    Cuaron, J. J.
    Yorke, E. D.
    Schefter, T.
    Jones, B. L.
    Vinogradskiy, Y.
    Crane, C. H.
    Goodman, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E70 - E71
  • [40] A phase I dose escalation trial of intravenous treosulfan in refractory cancer
    Harstrick, A
    Wilke, H
    Eberhardt, W
    Klaassen, U
    Strumberg, D
    Korn, M
    Scheulen, ME
    Baumgart, J
    Seeber, S
    ONKOLOGIE, 1996, 19 (02): : 153 - 156